These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20409682)
1. Activated protein C-protein C inhibitor complex in peripheral arterial disease. Blomstrand D; Kölbel T; Lindblad B; Gottsäter A Ann Vasc Surg; 2010 Jul; 24(5):588-95. PubMed ID: 20409682 [TBL] [Abstract][Full Text] [Related]
2. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex. Bhiladvala P; Strandberg K; Stenflo J; Holm J Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566 [TBL] [Abstract][Full Text] [Related]
3. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms. Kölbel T; Strandberg K; Mattiasson I; Stenflo J; Lindblad B J Vasc Surg; 2006 May; 43(5):935-9. PubMed ID: 16678686 [TBL] [Abstract][Full Text] [Related]
4. Activated protein C-protein C inhibitor complex in patients with abdominal aortic aneurysms: is it associated with diameter and growth rate? Kölbel T; Strandberg K; Donath T; Mattiasson I; Stenflo J; Lindblad B Vasc Endovascular Surg; 2008; 42(2):135-40. PubMed ID: 18184931 [TBL] [Abstract][Full Text] [Related]
5. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients. Bakoush O; Ohlin AK; Strandberg K; Kurkus J Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177 [TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Strandberg K; Svensson PJ; Ohlin AK Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343 [TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients. Matsumoto K; Yano Y; Gabazza EC; Araki R; Bruno NE; Suematsu M; Akatsuka H; Katsuki A; Taguchi O; Adachi Y; Sumida Y Diabet Med; 2007 Dec; 24(12):1322-8. PubMed ID: 17971179 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease. Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051 [TBL] [Abstract][Full Text] [Related]
10. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study. Dieplinger B; Haltmayer M; Poelz W; Mueller T Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980 [TBL] [Abstract][Full Text] [Related]
11. Coagulation activation and ultrasound characteristics in patients with carotid artery disease. Kölbel T; Goncalves I; Dias N; Strandberg K; Acosta S; Gottsäter A Thromb Res; 2010 Feb; 125(2):171-7. PubMed ID: 19796792 [TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098 [TBL] [Abstract][Full Text] [Related]
14. Combined assessment of chronic kidney disease and subclinical peripheral artery disease used to predict future cardiac events. Itaya H; Shiba M; Joki N; Nakamura M Nephrology (Carlton); 2010 Mar; 15(2):230-5. PubMed ID: 20470284 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction]. Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101 [TBL] [Abstract][Full Text] [Related]
16. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors]. Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199 [TBL] [Abstract][Full Text] [Related]
17. The plasma concentration of activated protein C appears normal in patients with haemophilia. Schulman S; Eelde A; Blombäck M; Stenflo J Haemophilia; 2009 Mar; 15(2):566-70. PubMed ID: 19175419 [TBL] [Abstract][Full Text] [Related]
18. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Beckman JA; Preis O; Ridker PM; Gerhard-Herman M Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181 [TBL] [Abstract][Full Text] [Related]
19. Activated protein C-protein C inhibitor complex, activation peptide of carboxypeptidase B and C-reactive protein as predictors of severe acute pancreatitis. Hjalmarsson C; Stenflo J; Borgström A Pancreatology; 2009; 9(5):700-7. PubMed ID: 19684435 [TBL] [Abstract][Full Text] [Related]
20. Decreased protein C activation in patients with fulminant hepatic failure. Yamaguchi M; Gabazza EC; Taguchi O; Yano Y; Ikoma J; Kaito M; Kojima Y; Imoto I; Satomi A; D'Alessandro-Gabazza CN; Hayashi T; Moriwaki H; Suzuki K; Adachi Y Scand J Gastroenterol; 2006 Mar; 41(3):331-7. PubMed ID: 16497622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]